Insights

Precision Medicines Maze Therapeutics is developing novel, small molecule precision medicines for common diseases, presenting an opportunity for partnership or collaboration in the healthcare sector.

Financial Investment With recent funding rounds totaling $381 million and partnerships with industry players like Sanofi, there is a potential for financial investors to explore opportunities for funding or equity investments in Maze Therapeutics.

Clinical Trials The initiation of Phase 1 clinical trials by Maze Therapeutics, such as the trial evaluating MZE782, could signal opportunities for clinical research organizations or pharmaceutical service providers to engage in collaborations.

Rare Disease Market Being involved in developing treatments for rare diseases like Pompe disease, Maze Therapeutics could attract interest from pharmaceutical companies seeking to enter or expand within the rare disease therapy market.

Genetic Insights Given Maze Therapeutics' focus on translating genetic insights into life-saving medicines, there may be potential for partnerships with genetic testing companies or biotech firms specializing in genetic research and development.

Similar companies to Maze Therapeutics

Maze Therapeutics Tech Stack

Maze Therapeutics uses 8 technology products and services including Cookie Notice, git, NetSuite, and more. Explore Maze Therapeutics's tech stack below.

Cookie Notice
Cookie Compliance
git
Development
NetSuite
E-commerce
Google Cloud
Infrastructure As A Service
jQuery
Javascript Libraries
Informa
Miscellaneous
GraphQL
Programming Languages
Google Tag Manager
Tag Management

Media & News

Maze Therapeutics's Email Address Formats

Maze Therapeutics uses at least 1 format(s):

Maze Therapeutics Email Formats	Example	Percentage
FLast@mazetx.com	JDoe@mazetx.com	93%
Last@mazetx.com	Doe@mazetx.com	5%
FMiddleLast@mazetx.com	JMichaelDoe@mazetx.com	2%

Frequently Asked Questions

Where is Maze Therapeutics's headquarters located?

Maze Therapeutics's main headquarters is located at 171 Oyster Point Blvd Suite 300 South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaEuropeAfrica.

What is Maze Therapeutics's official website and social media links?

Maze Therapeutics's official website is mazetx.com and has social profiles on LinkedIn.

How much revenue does Maze Therapeutics generate?

As of October 2024, Maze Therapeutics's annual revenue reached $15M.

What is Maze Therapeutics's SIC code NAICS code?

Maze Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Maze Therapeutics have currently?

As of October 2024, Maze Therapeutics has approximately 128 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: J. C.Chief Strategy Officer: A. D.Chief Medical Officer: S. N.. Explore Maze Therapeutics's employee directory with LeadIQ.

What industry does Maze Therapeutics belong to?

Maze Therapeutics operates in the Biotechnology Research industry.

What technology does Maze Therapeutics use?

Maze Therapeutics's tech stack includes Cookie NoticegitNetSuiteGoogle CloudjQueryInformaGraphQLGoogle Tag Manager.

What is Maze Therapeutics's email format?

Maze Therapeutics's email format typically follows the pattern of . Find more Maze Therapeutics email formats with LeadIQ.

How much funding has Maze Therapeutics raised to date?

As of October 2024, Maze Therapeutics has raised $190M in funding. The last funding round occurred on Jan 10, 2022 for $190M.

When was Maze Therapeutics founded?

Maze Therapeutics was founded in 2018.

Maze Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders.

Company Overview

Headquarters: 171 Oyster Point Blvd Suite 300 South San Francisco, California 94080 US
Website: mazetx.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2018
Employees: 51-200

Media & News

Funding & Financials

$190M
Maze Therapeutics has raised a total of $190M of funding over 3 rounds. Their latest funding round was raised on Jan 10, 2022 in the amount of $190M.
$10M$50M
Maze Therapeutics's revenue is in the range of $10M$50M

Funding & Financials

$190M
Maze Therapeutics has raised a total of $190M of funding over 3 rounds. Their latest funding round was raised on Jan 10, 2022 in the amount of $190M.
$10M$50M
Maze Therapeutics's revenue is in the range of $10M$50M

Company Leadership

J. C.
Chief Executive Officer
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. D.
Chief Strategy Officer
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. N.
Chief Medical Officer
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Vice President Nonclinical Development
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. B.
Head Of Pharmacology
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

K. E.
Vp Translational Genomics
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. B.
Senior Vice President Finance
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. L.
Vp, Clinical Science
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. V.
Vice President, R & D Infrastructure And Operations
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. B.
Head Of Pharmacology
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Maze Therapeutics and Millions of Other Companies
Sign up for full access to Maze Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Maze Therapeutics

Guardant Health

BlackThorn Therapeutics

Neogene Therapeutics

Tenaya Therapeutics

Schrödinger

Editas Medicine

CRISPR Therapeutics

Revolution Medicines

FogPharma

Denali Therapeutics

Maze Therapeutics Tech Stack

Media & News

Maze Therapeutics, Inc. is developing novel, small molecule precision medicines for patients living with common diseases on Oct 1st '24.

Maze Therapeutics, Inc. launches player in the Pompe disease therapy market.

Sanofi partnered with Maze Therapeutics, Inc. on May 1st '23.

Maze Therapeutics, Inc. is developing Pompe disease.

Maze Therapeutics, Inc. receives financing of $381M in private financing.

Maze Therapeutics, Inc. receives financing of $150M in cash and an equity investment.

Maze Therapeutics, Inc. is developing Pompe disease on Nov 27th '22.

Maze Therapeutics's Email Address Formats

Frequently Asked Questions

Where is Maze Therapeutics's headquarters located?

What is Maze Therapeutics's official website and social media links?

How much revenue does Maze Therapeutics generate?

What is Maze Therapeutics's SIC code NAICS code?

How many employees does Maze Therapeutics have currently?

What industry does Maze Therapeutics belong to?

What technology does Maze Therapeutics use?

What is Maze Therapeutics's email format?

How much funding has Maze Therapeutics raised to date?

When was Maze Therapeutics founded?

Maze Therapeutics

Company Overview

Media & News

Maze Therapeutics, Inc. is developing novel, small molecule precision medicines for patients living with common diseases on Oct 1st '24.

Maze Therapeutics, Inc. launches player in the Pompe disease therapy market.

Sanofi partnered with Maze Therapeutics, Inc. on May 1st '23.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?